SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-027644
Filing Date
2012-05-10
Accepted
2012-05-10 16:20:49
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v312099_10q.htm 10-Q 542721
2 EXHIBIT 10.1 v312099_ex10-1.htm EX-10.1 103382
3 EXHIBIT 31.1 v312099_ex31-1.htm EX-31.1 11029
4 EXHIBIT 31.2 v312099_ex31-2.htm EX-31.2 10751
5 EXHIBIT 32.1 v312099_ex32-1.htm EX-32.1 4588
6 EXHIBIT 32.2 v312099_ex32-2.htm EX-32.2 4515
  Complete submission text file 0001144204-12-027644.txt   2804868

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT scmp-20120331.xml EX-101.INS 341248
8 XBRL TAXONOMY EXTENSION SCHEMA scmp-20120331.xsd EX-101.SCH 13868
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20120331_cal.xml EX-101.CAL 45171
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20120331_def.xml EX-101.DEF 113914
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20120331_lab.xml EX-101.LAB 150278
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20120331_pre.xml EX-101.PRE 135408
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 12830566
SIC: 2834 Pharmaceutical Preparations